Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Before investing in cryptocurrency, it's crucial to understand the market. Learn key insights to prepare yourself for potential investments.
24,812 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Target’s new chief executive Michael Fiddelke unveils a candor-driven plan to revive growth after a sales slump. The ...
A Seattle wage rule for gig-delivery drivers raised base pay, but researchers say monthly take-home barely rose as dr...
Vipshop (VIPS) has carved a niche in discount e-commerce. This guide breaks down what to watch in the 2025 earnings s...
A seven-figure portfolio and Social Security offset still leave gaps as healthcare costs and taxes erode purchasing p...
Retail investors sold NVIDIA, Microsoft, and Oracle to fund SpaceX private rounds, signaling a major shift in how eve...
Dell Technologies surged 248% from year-end 2025 to midsummer 2026, sparking a parallel rally in the IGPT AI ETF. Thi...
Goodyear reports a strong Q4 with $105 million in profit, while an investor increases exposure to $15 million. This p...
As mortgage markets wobble in March 2026, Ninja Selling’s Larry Kendall champions a habit-first approach for loan off...
Jack Schlossberg, JFK’s grandson and Manhattan candidate, says Democrats lost touch with young men and explains why h...
A potential executive action could index capital gains to inflation, changing cost basis and tax bills. The kiplinger...
AI is slashing underwriting time and accelerating document checks, but the real story is how regulatory guardrails ar...